logo
Login
Open Account
Open Demat

Sector: Pharmaceuticals & Biotechnology

|

Mid Cap

Marksans Pharma Share Price

Marksans Pharma Ltd.

₹174.90

0.30(0.17%)

Invest in MARKSANS with up to 2.22x margin.

Trade with MTF
9th Apr 2026 | 3:28 PM
NSE : MARKSANS
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Marksans Pharma Performance

Price Movement

₹174.90

₹173.39

₹178.50

↘ Today's Low↗ Today's High

1 Year Performance

₹174.90

₹155.00

₹270.70

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹178.50
Low₹173.39
Open at₹176.00
Prev Close₹174.60
Volumes5.50 L
Avg Price₹175.90
Lower Circuit₹139.68
Upper Circuit₹209.52

Historical Performance

3M High₹191.74
3M Low₹155.00
1 Yr High₹270.70
1 Yr Low₹155.00
3 Yr High₹358.70
3 Yr Low₹70.55
5 Yr High₹358.70
5 Yr Low₹38.60

Marksans Pharma Fundamentals

Market Cap
Above industry Median
7,929.50 Cr.
PE Ratio (TTM)
Above industry Median
22
Dividend Yield
Below industry Median
0.50
Net Profit TTM
2% decr over last year
360.32
Net Profit Growth
2% decr over last year
360.32
PEG Ratio
Negative PEG TTM
-10.10
ROE
1.5% incr over last year
15.42
Operating Revenue TTM
2,803.28
Operating Revenue Growth
13.3% incr over last year
Book Value
Above industry Median
2.80
MFI
MFI is mid-range
61.90
RSI
RSI is mid-range
55.62
EPS (TTM)
8.40
Debt to Equity
0.01
Face Value
1
Operating Profit Margin Qtr.
19.63
Operating Profit Qtr.
160.74
Net Profit Qtr.
113.20
Operating Revenue Qtr.
754.43
PB Ratio
2.80

Marksans Pharma Financials

*All values are in Rs. Cr
Loading chart...
Indicator
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Total Revenue339.73320.44319.73299.36311.86
Operating Expense264.28248.37249.68248.78251.92
Operating Profit75.4472.0870.0550.5759.94
Depreciation8.838.468.198.187.42
Interest0.360.320.300.310.30
Tax21.2021.6915.5212.3119.26
Net Profit60.9199.8148.0637.5955.46

Marksans Pharma Technicals

Marksans Pharma Ltd. EMA & SMA

₹174.90

0.30 (0.17%)

↗ Bullish Moving Average

11

↘ Bearish Moving Average

5

Day EMA5 ₹169.6
Day EMA10 ₹167.8
Day EMA12 ₹167.7
Day EMA20 ₹168.2
Day EMA26 ₹168.8
Day EMA50 ₹171.6
Day EMA100 ₹177
Day EMA200 ₹188.7

Marksans Pharma Support and Resistance

Resistance

First Resistance₹176.40
Second Resistance₹178.20
Third Resistance₹180.40

Support

First Support₹172.40
Second Support₹170.20
Third Support₹168.40

Technical Indicators

Day RSI55.62
Day MFI61.90
Day ADX13.37
Day Commodity Channel Index157.10
William-6.67
Day MACD-1.16
Day MACD Signal Line-2.39
Day ATR7.47
Day ROC1254.85
Day ROC210.45

Marksans Pharma Shareholding Pattern

Held BySep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoter43.943.943.943.943.943.9
FII21.32222.219.916.98.1
DII4.14.24.55.55.35.9
Public30.729.929.430.733.942.1

Marksans Pharma Delivery And Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume AvgDaily Avg Delivery Volume %
Day2.94 L6.77 L43.42%
Week2.71 L6.98 L38.80%
1 Month3.79 L7.84 L48.28%
6 Month3.99 L9.46 L42.22%

Marksans Pharma SWOT Analysis

Strengths16
Weakness3
Opportunity4
Threats0

Benjamin Graham Value Screen

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE

Mid-range Performer (DVM)

Relative Outperformance versus Industry over 1 Month

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Growth in Net Profit with increasing Profit Margin (QoQ)

Companies with Low Debt

Increasing Revenue every quarter for the past 2 quarters

Increasing profits every quarter for the past 2 quarters

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

RSI indicating price strength

Top Gainers

Marksans Pharma Corporate Action

Ex-Date
Dividend Amount
Dividend Type
Record Date
Instrument Type
01 Aug, 20250.8FINAL01 Aug, 2025Equity Share
17 Sep, 20240.6FINAL17 Sep, 2024Equity Share
07 Jun, 20230.5FINAL07 Jun, 2023Equity Share
19 Aug, 20220.25FINALEquity Share
15 Sep, 20210.25FINALEquity Share
22 Sep, 20200.1FINALEquity Share
19 Sep, 20190.05FINALEquity Share
19 Sep, 20180.05FINALEquity Share
19 Sep, 20170.05FINALEquity Share
22 Sep, 20160.12FINALEquity Share

Marksans Pharma Stock Comparison

Financials
Corona Remedies Ltd.
Sudeep Pharma Ltd.
Rubicon Research Ltd.
Viyash Scientific Ltd.
Sanofi India Ltd.
Procter & Gamble Health Ltd.
Price (₹)₹1,565₹613.90₹864₹209₹3,450₹4,800
% Change0.66%-0.35%8.20%1.97%-0.39%-0.04%
Revenue TTM (₹ Cr)--₹1,598.19₹2,125.52₹1,837.40₹1,348.51
Net Profit TTM (₹ Cr)--₹206.20₹76.81₹326.70₹293.49
PE TTM--68.60116.6024.4027.20
1 Year Return47.073.4276.5449.69-43.98-6.09
ROCE30.2434.7834.7610.0352.72-

Similar Stocks

JSLL

Jeena Sikho Lifecare Ltd.

₹ 650.70

-0.02%

ONESOURCE

OneSource Specialty Pharma Ltd.

₹ 1370.00

+1.97%

SANOFICONR

Sanofi Consumer Healthcare India Ltd.

₹ 4550.00

+1.57%

AKUMS

Akums Drugs & Pharmaceuticals Ltd.

₹ 492.20

-2.52%

BLUEJET

Blue Jet Healthcare Ltd

₹ 370.00

-1.20%

CONCORDBIO

Concord Biotech Ltd.

₹ 1059.00

+0.88%

AARTIPHARM

Aarti Pharmalabs Ltd.

₹ 679.00

-1.34%

PPLPHARMA

Piramal Pharma Ltd.

₹ 143.50

-0.19%

SUPRIYA

Supriya Lifescience Ltd.

₹ 626.70

-1.61%

ACUTAAS

Acutaas Chemicals Ltd.

₹ 2339.80

+0.17%

ALIVUS

Alivus Life Sciences Ltd.

₹ 1040.55

-0.35%

COHANCE

Cohance Lifesciences Ltd.

₹ 320.00

+3.39%

ERIS

Eris Lifesciences Ltd.

₹ 1364.00

+1.04%

SYNGENE

Syngene International Ltd.

₹ 394.50

-1.14%

APLLTD

Alembic Pharmaceuticals Ltd.

₹ 720.00

-0.86%

STAR

Strides Pharma Science Ltd.

₹ 995.00

+3.17%

GRANULES

Granules India Ltd.

₹ 634.20

-1.57%

FDC

FDC Ltd.

₹ 341.50

-1.26%

SHILPAMED

Shilpa Medicare Ltd.

₹ 418.65

+3.70%

JUBLPHARMA

Jubilant Pharmova Ltd.

₹ 871.85

-0.67%

NATCOPHARM

Natco Pharma Ltd.

₹ 1127.00

+1.31%

CAPLIPOINT

Caplin Point Laboratories Ltd.

₹ 1659.90

-0.02%

NEULANDLAB

Neuland Laboratories Ltd.

₹ 14726.00

+4.77%

FAQ's on MARKSANS

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy